Vanderbilt Health and Eli Lilly are developing an AI agent to speed Alzheimer's disease treatment, with plans for radiology-focused AI tools.
Key Details
- 1Vanderbilt Health received a $600,000 grant from Eli Lilly to build an AI triage agent for Alzheimer's care in the EHR system.
- 2The AI tool will streamline referrals, summarize charts, flag missing details, and prioritize cases, aiming to reduce wait times for monoclonal antibody treatment.
- 3The project will be piloted with data from over 5,300 patients at Vanderbilt Health, targeting reduced time from diagnosis to infusion.
- 4Plans include a second AI agent to analyze MRI images and generate Alzheimer's safety reports for radiologists, and a third to support insurance authorization.
- 5Outcomes will be measured by reduced delays across the dementia care pathway.
Why It Matters
The integration of AI triage and radiology-focused agents aims to address bottlenecks in Alzheimer's care, supporting faster and more accurate treatment. Success here could set a model for scalable, AI-enhanced workflows across radiology and neurology.
Source
EurekAlert
Related News
•EurekAlert
AI Achieves Precision in Generating Radar Images at Specific Attitudes
Researchers introduce a ControlNet-based AI method for precise, attitude-controllable radar image generation of noncooperative targets.
•EurekAlert
RADAR AI Sets New Standard in Abdominal CT Diagnosis
The RADAR vision-language AI model shows expert-level diagnostic ability for abdominal CT across multiple diseases and clinical settings.
•EurekAlert
UCSD Unveils 4D AI Virtual Cell Models to Accelerate Drug Discovery
UC San Diego researchers have developed AI-powered virtual cell models using 4D imaging to predict cellular responses to drugs, potentially expediting drug development.